The Surrogacy Process for Gay Men
Surrogacy is a wonderful option for gay male couples who are looking to grow their family. We review everything you need to know about the process here.
Abuse of the genetic testing industry, when only one ovary responds to stimulation, and more
Abuse of the genetic testing industry, when only one ovary responds to stimulation, and more: April 2019 CHR VOICE Digest
Reflecting the increasing importance of genetics in all areas of medicine, reproductive medicine of course included, this issue of the _VOICE _contains two major articles pertaining to genetics. In our lead article for the month, we are discussing the relatively new scientific field of “epigenetics,” which, in turn, has revolutionized genetics in general. After the good, we also have to talk a little bit about the not-so-good, and are addressing how the rapidly growing genetic lab testing industry is not always doing things in the best interest of the public and treating physicians. As always, not everybody will agree with our position on the subject, but we, of course, welcome critical comments.
In addition, we continue with our very popular series of Questions from the Public as we address this time the possible side effects of DHEA supplementation and what happens when only one ovary responds to stimulation for IVF. As always, when we address here androgen supplementation of any kind (including DHEA supplementation), please remember that CHR and CHR investigators are listed on quite a number of U.S. patents as inventors and receive royalties from companies that sell DHEA in order to improve female fertility. An additional DHEA patent, which addresses the positive effects of DHEA supplementation on female sexual wellbeing, is currently pending. This is a subject not discussed widely enough, and, therefore, also subject of a brief article in this issue of the VOICE. Considering the commercial connotations of those patents, please consider potential conflicts of interests when reading these articles.
In this issue of the VOICE, we cover:
- Have you heard of EPIGENETICS?
- Trusting the genetic testing industry is getting harder still
- What are the side effects of DHEA?
- What can be done when only one ovary responds to IVF stimulation?
- New York state mandates IVF insurance coverage and fertility preservation insurance for young cancer patients
- Female sexual wellbeing in pre-menopausal women: A new indication for DHEA
- What's behind higher cancer risk for IVF kids & Harvard debate on mitochondrial replacement therapy: CHR in the media
Norbert Gleicher, MD, FACOG, FACS
Norbert Gleicher, MD, leads CHR’s clinical and research efforts as Medical Director and Chief Scientist. A world-renowned specialist in reproductive endocrinology, Dr. Gleicher has published hundreds of peer-reviewed papers and lectured globally while keeping an active clinical career focused on ovarian aging, immunological issues and other difficult cases of infertility.
We have helped women bring over
17,800 babies into the world.
DISCOVER YOUR TREATMENT OPTIONS
You Might Also Enjoy...
The September VOICE
Welcome to the September VOICE!
Poor Egg Quality and IVF
A natural part of female aging is a decline in egg count and quality. If this decrease in quality eggs happens too soon, it’s known as diminished ovarian reserve (DOR). Learn how in vitro fertilization (IVF) can address infertility due to DOR.
Affordable Egg Freezing
Do you want to put off having children for a few years, but you’re worried about not having enough quality eggs? Find out how you can be in total control of your fertility through the empowering process known as egg freezing.
What Every Cancer Patient Should Know About Fertility Preservation
Although it may be difficult to think about future children after receiving a cancer diagnosis, getting prompt medical care to preserve your ability to conceive is vital. We discuss what you need to know about fertility preservation here.
The June Voice
Welcome to the June VOICE!